Annual Meeting Program Chairs Keith T. Flaherty, MD, FAACR, and Christina Curtis, PhD, MSc, preview notable items on Tuesday’s schedule, including a major symposium on President Biden’s Cancer Moonshot featuring Danielle Carnival, PhD, from the Executive Office of the President.

Carlos L. Arteaga, MD, FAACR, and Virginia G. Kaklamani, MD, will highlight important developments from the San Antonio Breast Cancer Symposium on Tuesday.

Kevan M. Shokat, PhD, FAACR, will chair a Tuesday afternoon session on the latest understanding of KRAS mutation targets beyond G12C.

Yin Cao, ScD, MPH, will chair a Tuesday morning session on the prevention and treatment of early-onset cancers.

Tony S. K. Mok, MD, will chair a Tuesday afternoon session looking into early disease detection, resistance to targeted therapy, and application of immunotherapy for lung cancer in non-smokers.

Tuesday forums will cover topics including real-world data, small-molecule inhibitors, trust in science, lifestyle choices to improve health equity, and multiple mechanisms of resistance.

Aviv Regev, PhD, FAACR; Jakob Nikolas Kather, MD, MSc; Benjamin F. Cravatt, PhD; and Carolyn R. Bertozzi, PhD, FAACR, described evolving and emerging technological advances—from cell atlases and artificial intelligence-based biomarkers to proteomics and bioorthogonal chemistry—that are driving new discoveries and new directions in cancer research.

Margaret A. Goodell, PhD, FAACR, presented how clonal hematopoiesis can drive tumor risk and resistance during a Saturday plenary session on discovery science in early cancer biology and interception.

Annual Meeting Program Chairs Keith T. Flaherty, MD, FAACR, and Christina Curtis, PhD, MSc, preview notable items on Monday’s schedule to help you plan your day.

Michael N. Pollak, MD, will chair a Monday symposium on novel and exciting data-driven insights on obesity, nicotine addiction, and suboptimal dietary patterns.